Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bukuryoingohangekobokuto is a Kampo (Japanese traditional herbal) medicine that represents a combination of two distinct formulas: Bukuryoin and Hangekobokuto. It is traditionally indicated for gastrointestinal disorders, particularly those involving bloating, nausea, and the sensation of a foreign body in the throat (globus pharyngeus). The formula is composed of several botanical extracts, including Poria Sclerotium, Pinellia Tuber, and Magnolia Bark. In modern clinical research, it is being investigated for its efficacy in treating aerophagia (pathological air swallowing) in pediatric and young adult populations, where it is hypothesized to reduce intestinal gas and improve gastric emptying by enhancing gastrointestinal motility and addressing psychosomatic symptoms.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on bukuryoingohangekobokuto.